Skip to content

U.S. Clears Merck’s Covid Pill as It Weighs How to Ration Pfizer

  • Merck pill authorized Thursday for cases with no other options
  • U.S. ordered 10 million courses of Pfizer, 3 million of Merck
Pfizer's Covid-19 pills

Pfizer's Covid-19 pills

Source: Pfizer/AP Photo

Updated on

The U.S. has cleared its first two Covid-19 treatment pills, and now comes another hurdle -- deciding who should get which one.

Merck & Co.’s molnupiravir was authorized Thursday by the Food and Drug Administration for use in adults at high risk of severe cases who have no other treatment option, though it is not recommended for pregnant women. Still, the U.S. will soon have 3 million courses available.